GLP-1 drugs combined with healthy lifestyle habits linked to reduced cardiovascular risk among diabetes patients

Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and the Department of Veterans Affairs Boston Healthcare System.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup